Second, the off-label adoption pattern that the longevity reframing will inevitably accelerate is going to produce the next wave of monitoring, dosing, and selection problems, patients without obesity or diabetes do not have the diagnostic anchors (BMI, A1c, insulin resistance markers) that frame the on-label conversation, and the clinical infrastructure for managing GLP-1 therapy in metabolically healthy users is, charitably described, thin
(00:06:15) Sleep Hunger (00:09:00) Caffeine: Devil & Angel (00:12:20) Timing Your Sleep Properly (00:14:15) Release Your Hormones (At The Right Times) (00:18:45) (Pineal) Melatonin Waring (00:24:30) Strange Vision Is Good Vision (00:32:50) Blue Light Is Great
Additionally, the medication's impact on weight loss and potential nutritional changes might contribute to hair thinning
If these changes are not sustained, the risk of weight regain may increase